相关实验视频
Updated: Jul 14, 2026
13:42
A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion
Published on: July 17, 2012
28.9K
罗激酶抑制剂Y-27632降低了实验性自身免疫性心肌炎的小鼠中的IL-1β表达
Yanjun Li1, Ge Gao1, Yiru Han1
1Institute of Immunology, Shanxi Datong University School of Medicine, Datong, Shanxi, China.
Scientific reports
|April 29, 2024
概括
罗激酶 (ROCK) 抑制剂Y-27632治疗对小鼠的实验性自身免疫性心肌炎 (EAM) 进行了保护. Y-27632通过降低干白素-1β (IL-1β) 表达的调节,减少了炎症和纤维化.
科学领域:
- 心血管研究研究心血管研究
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自身免疫性心肌炎涉及来自免疫系统功能障碍的心肌炎症.
- 实验性自身免疫性心肌炎 (EAM) 鼠标模型对于研究疾病机制至关重要.
研究的目的:
- 在自免疫性心肌炎的小鼠模型中研究Rho激酶 (ROCK) 抑制剂Y-27632的保护作用.
- 阐明Y-27632在EM的治疗作用背后的分子机制.
主要方法:
- 在小鼠中使用MyHC-α614-629.9来诱导EAM.
- 在二次免疫接种后,小鼠接受了Y-27632的腹腔内注射.
- 分析心脏组织和脏病理变化,基因表达 (Notch通路, Tlr2, IL-1β) 和单细胞计数.
主要成果:
- EAM小鼠表现出心脏膨胀,心脏重量/体重比率增加,心肌炎症和纤维化恶化.
- Y-27632治疗改善了这些病理特征.
- Y-27632降低了诺奇信号通路基因 (Notch1,Hes1,Jag2,Dil1),托尔类受体2 (Tlr2) 和互白素-1β (IL-1β) 的表达,并降低了脏单细胞数.
结论:
- ROCK抑制剂Y-27632在实验性自身免疫性心肌炎中显示出显著的保护作用.
- 治疗机制涉及IL-1β表达的下调,可能与Notch信号通路和Tlr2.2相关.
- 这些发现表明Y-27632作为临床心肌炎治疗的潜在治疗剂.
更多相关视频
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
8.3K
08:00Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
6.1K
相关概念视频
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...